SYNALAR-HP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Synalar-hp, and what generic alternatives are available?
Synalar-hp is a drug marketed by Medimetriks Pharms and is included in one NDA.
The generic ingredient in SYNALAR-HP is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Synalar-hp
A generic version of SYNALAR-HP was approved as fluocinolone acetonide by TARO on April 27th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SYNALAR-HP?
- What are the global sales for SYNALAR-HP?
- What is Average Wholesale Price for SYNALAR-HP?
Summary for SYNALAR-HP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Clinical Trials: | 2 |
| Patent Applications: | 5,146 |
| DailyMed Link: | SYNALAR-HP at DailyMed |
Recent Clinical Trials for SYNALAR-HP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Noah Rosenberg, MD | Phase 4 |
| LEO Pharma | Phase 1 |
US Patents and Regulatory Information for SYNALAR-HP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medimetriks Pharms | SYNALAR-HP | fluocinolone acetonide | CREAM;TOPICAL | 016161-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
